US Patent Issued to St. Jude Children's Research Hospital, University of Maryland, Baltimore on Jan. 20 for "T-cell receptor for treating fibrolamellar hepatocellular carcinoma" (Tennessee Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,853, issued on Jan. 20, was assigned to St. Jude Children's Research Hospital Inc. (Memphis, Tenn.) and University of Maryland, Baltimore (Baltimore).

"T-cell receptor for treating fibrolamellar hepatocellular carcinoma" was invented by Paul Thomas (Memphis, Tenn.), Jeremy Crawford (Memphis, Tenn.), Allison Kirk (Memphis, Tenn.), Anthony Zamora (Memphis, Tenn.) and Scott E. Strome (Memphis, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A vector harboring nucleic acids encoding a recombinant T cell receptor having antigenic specificity for a DnaJ heat shock protein family member B1-protein kinase cAMP-activated catalytic subunit alpha (DNAJB1-...